PhD, MSPH
Associate Professor, Epidemiology
Gillings School of Global Public Health
UNC-Chapel Hill
Cancer Epidemiology
Area of Interest
I conduct pharmacoepidemiologic and comparative effectiveness research with applications to older adult populations and those diagnosed with cancer. The overall objective of my work is to generate robust evidence on the utilization and effects of medical interventions that will inform decisions made by patients, their caregivers, healthcare providers, and policymakers.
Together with a team of trainees and collaborators, my research program draws upon clinical trials, large healthcare databases, and advanced epidemiologic methods to evaluate:
- The quality of care received
- The effectiveness and safety of treatment options
- The role of polypharmacy, multimorbidity, and frailty in treatment selection, adherence, and outcomes
Awards and Honors
- Fellow Designation, International Society for Pharmacoepidemiology (ISPE), 2021
- Young Investigator Award, Finalist, International Society of Geriatric Oncology (SIOG), 2019
- American Society of Preventive Oncology, Honorable Mention, Poster Award, New York, NY, 2018
- Gordon H. DeFriese Career Development in Aging Research Award, UNC-Chapel Hill, 2015
- Abstract Achievement Award winner, American Society of Hematology, 2013
News and Stories
Researchers receive five-year, $1.2 million ACS grant to develop, test new methods to track cancer screening
A group of UNC Lineberger researchers led by Katie Reeder-Hayes, MD, MSc, MBA, will develop new methods to measure and map cancer screening across North Carolina.
Lund, Henderson awarded NCI grant to study impacts of low-dose CT lung cancer screening outside clinical trials
Jennifer Lund, PhD, MSPH, and Louise Henderson, PhD, will use the $1.76 million grant to study the real-world benefits and harms of lung cancer screening with low-dose computed tomography.
UNC Lineberger faculty present research at the American Society of Clinical Oncology annual meeting
UNC Lineberger members will be presenting research findings, providing commentary and leading education sessions at the American Society of Clinical Oncology’s 58th annual meeting.
Henderson, Rivera awarded $1.5 million lung cancer screening study grant
Louise Henderson, PhD, M. Patricia Rivera, MD, ATSF, and a multi-disciplinary team will study comorbidity and functional status in a population undergoing lung cancer screening.
